Press Releases

AxelaRx and Avelas Join Forces to Accelerate the Development of Promising Nerve Imaging Agents

AxelaRx Biosciences Inc. (“AxelaRx”), a leading specialist accelerating the development of novel drugs and diagnostics and Avelas Biosciences Inc. (“Avelas”), an innovator and pioneer in the field of fluorescent diagnostic imaging, have agreed to enter a strategic partnership to develop novel imaging agents that visualize nerves intraoperatively. Under the [...]

AxelaRx and Avelas Join Forces to Accelerate the Development of Promising Nerve Imaging Agents2020-06-04T08:32:39+00:00

Exotome becomes first Portfolio Company of AxelaRx

Invisible tumor cells often migrate beyond the edge of the primary tumor. Exotome is developing a dual-purpose theranostic agent that fluoresces in real-time, optimizing curative surgery results, and simultaneously ablates migrating tumor cells on a molecular level. We are excited to have Exotome on board and start the acceleration [...]

Exotome becomes first Portfolio Company of AxelaRx2020-05-27T21:11:08+00:00
Go to Top